Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
RESEARCH TOOLSreports
Holding RARE?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 139.49M | $ 147.03M | $ 108.83M | $ 127.39M | $ 98.05M |
| Gross Profit | $ 139.49M | $ 147.03M | $ 108.83M | $ 103.08M | $ 98.05M |
| EBIT | $ -133.21M | $ -130.74M | $ -154.38M | - | $ -159.00M |
| EBITDA | $ -124.46M | $ -118.12M | $ -145.54M | - | $ -151.81M |
| Net Income Common Stockholders | $ -133.52M | $ -131.60M | $ -170.68M | $ -123.19M | $ -159.65M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 621.61M | $ 763.82M | $ 412.08M | $ 577.21M | $ 442.09M |
| Total Assets | $ 1.54B | $ 1.62B | $ 1.31B | $ 1.49B | $ 1.24B |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -621.61M | $ -763.82M | $ -412.08M | $ -577.21M | $ -442.09M |
| Total Liabilities | $ 1.18B | $ 1.19B | $ 1.17B | $ 1.22B | $ 1.21B |
| Stockholders Equity | $ 346.83M | $ 432.42M | $ 140.26M | $ 275.41M | $ 31.71M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -68.61M | $ -81.47M | $ -203.94M | - | $ -121.57M |
| Operating Cash Flow | $ -67.00M | $ -76.96M | $ -190.73M | $ -83.90M | $ -117.87M |
| Investing Cash Flow | $ -275.50M | $ 60.56M | $ 94.44M | $ -107.02M | $ 64.30M |
| Financing Cash Flow | $ 11.17M | $ 384.94M | $ -58.00K | $ 330.61M | $ 25.23M |